<DOC>
	<DOC>NCT01093547</DOC>
	<brief_summary>Phase IV post-marketing study to evaluate the effect of Extraneal on the HOMA index in non-diabetic CAPD patients over the long-dwell exchange. The purpose of the study is to investigate if the use of Extraneal (which is a mixture of high weight glucose polymers), instead of glucose-based solutions such as Dianeal is going to lower the HOMA index in non-diabetic CAPD patients.</brief_summary>
	<brief_title>Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Icodextrin</mesh_term>
	<criteria>must be over 18years old and under 75years old Peritoneal Equilibration Test (PET) result of high, high average or low average transport nondiabetic patient be in Continuous Ambulatory Peritoneal Dialysis (CAPD) prevalent patients that have been in peritoneal dialysis at least 30 days wish to participate Have a Charlson score of &gt;7 and have a life expectancy of less than 12 months HIV positive present with peritonitis in the month prior to randomisation present with cardiovascular, metabolic or infection complications that have required hospitalisation in the month prior to the randomisation have active cancer pregnant women patients with known allergy to starchbased polymer patients who have a significant psychiatric disorder or mental disability that could interfere with the patientÂ´s ability to provide Informed Consent and comply with the protocol procedures women incapable of maintaining an effective and accepted contraception method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>